Wagging the dog: Antibiotic use and the emergence of resistance

Journal of General Internal Medicine

Volumn 14, Issue 10, 1999, Pages 643-645

  Lautenbach, E ^a   Fishman, N O ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAMASE; COTRIMOXAZOLE; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; DRUG EFFICACY; EDITORIAL; HAEMOPHILUS INFLUENZAE TYPE A; HUMAN; HUMAN CELL; HUMAN TISSUE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTOR; URINARY TRACT INFECTION; URINE CULTURE;

EID: 0032700957     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.1999.07029.x     Document Type: Editorial

References (17)

1. 1. HS Gold RC Moellering 1996 Antimicrobial-drug resistance N Engl J Med 335 1445 53 8875923 10.1056/NEJM199611073351907 1:CAS:528:DyaK28Xnt1SnsLc%3D Gold HS, Moellering RC. Antimicrobial-drug resistance. N Engl J Med. 1996;335:1445–53.
2. 2. ML Cohen 1992 Epidemiology of drug resistance: implications for a post-antimicrobial era Science 257 1050 5 1509255 10.1126/science.257.5073.1050 1:STN:280:By2A2snltF0%3D Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992;257:1050–5.
3. 3. RF Breiman JC Butler FC Tenover JA Elliot RR Facklam 1994 Emergence of drug-resistant pneumococcal infections in the United States JAMA 271 1831 5 8196139 10.1001/jama.271.23.1831 1:STN:280:ByuB2MvhvFc%3D Breiman RF, Butler JC, Tenover FC, Elliot JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA. 1994;271:1831–5.
4. 4. KE Smith JM Besser CW Hedberg 1999 Quinolone-resistant campylobacter jejuni infections in Minnesota, 1992–1998 N Engl J Med 340 1525 32 10332013 10.1056/NEJM199905203402001 1:STN:280:DyaK1M3kslKksA%3D%3D Smith KE, Besser JM, Hedberg CW, et al. Quinolone-resistant campylobacter jejuni infections in Minnesota, 1992–1998. N Engl J Med. 1999;340:1525–32.
5. 5. K Gupta D Scholes WE Stamm 1999 Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women JAMA 281 736 8 10052444 10.1001/jama.281.8.736 1:CAS:528:DyaK1MXhs1yktLk%3D Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999;281:736–8.
6. 6. SW Wright KD Wrenn ML Haynes 1999 Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates: prevalence and risk factors J Gen Intern Med 10 606 609 10.1046/j.1525-1497.1999.10128.x Wright SW, Wrenn KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates: prevalence and risk factors. J Gen Intern Med. 1999;10:606–609.
7. 7. UD Allen N MacDonald L Fuite F Chan D Stephens 1999 Risk factors for resistance to “first-line” antimicrobials among urinary tract isolates of Escherichia coli in children CMAJ 160 1436 40 10352632 1:STN:280:DyaK1M3otVyqug%3D%3D Allen UD, MacDonald N, Fuite L, Chan F, Stephens D. Risk factors for resistance to “first-line” antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ. 1999;160:1436–40.
8. 8. RC Moellering 1990 Interaction between antimicrobial consumption and selection of resistant bacterial strains Scand J Infect Dis Suppl 70 18 24 2287899 Moellering RC. Interaction between antimicrobial consumption and selection of resistant bacterial strains. Scand J Infect Dis Suppl. 1990;70:18–24.
9. 9. S Ferry LG Burman SE Holm 1988 Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing Scand J Infect Dis 20 535 44 3065927 1:STN:280:BiaC3s%2FgsVQ%3D Ferry S, Burman LG, Holm SE. Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing. Scand J Infect Dis. 1988;20:535–44.
10. 10. JP Burke 1998 Antibiotic resistance-squeezing the balloon? JAMA 280 1270 1 9786379 10.1001/jama.280.14.1270 1:STN:280:DyaK1M%2FgtVentw%3D%3D Burke JP. Antibiotic resistance-squeezing the balloon? JAMA. 1998;280:1270–1.
11. 11. J Ena M Lopez-Perezagua C Martinez-Peinado M Cia-Barrio I Ruiz-Lopez 1998 Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones Diagn Microbiol Infect Dis 30 103 7 9554177 10.1016/S0732-8893(97)00216-2 1:CAS:528:DyaK1cXhvVyhtr4%3D Ena J, Lopez-Perezagua M, Martinez-Peinado C, Cia-Barrio M, Ruiz-Lopez I. Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones. Diagn Microbiol Infect Dis. 1998;30:103–7.
12. 12. J Ena C Amador C Martinez V Ortiz 1995 Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli J Urology 153 117 20 10.1097/00005392-199501000-00040 1:STN:280:ByqD2MnhvFM%3D Ena J, Amador C, Martinez C, Ortiz V. Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urology. 1995;153:117–20.
13. 13. B Schwartz L Barden S Dowell C Lackey 1998 Why doctors overprescribe antibiotics: results of focus group discussions with pediatricians (Ped) and family physicians (FP) and application to a resistance prevention campaign (abstract) International Conference on Emerging Infectious Diseases Centers for Disease Control and Prevention Atlanta, GA Schwartz B, Barden L, Dowell S, Lackey C. Why doctors overprescribe antibiotics: results of focus group discussions with pediatricians (Ped) and family physicians (FP) and application to a resistance prevention campaign (abstract). In: International Conference on Emerging Infectious Diseases. Atlanta, GA: Centers for Disease Control and Prevention, 1998.
14. 14. LF McCaig JM Hughes 1995 Trends in antimicrobial drug prescribing among office-based physicians in the United States JAMA 273 214 9 7807660 10.1001/jama.273.3.214 1:STN:280:ByqC3cnkt1A%3D McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273:214–9.
15. 15. TJM Verjeij J Hermans JD Mulder 1994 Effects of doxycycline in patients with acute cough and purulent sputum: a double-blind, placebo-controlled trial Br J Fam Pract 44 400 4 Verjeij TJM, Hermans J, Mulder JD. Effects of doxycycline in patients with acute cough and purulent sputum: a double-blind, placebo-controlled trial. Br J Fam Pract. 1994;44:400–4.
16. 16. R Gonzales JF Steiner A Lum PH Barrett 1999 Decreasing antibiotic use in ambulatory practice JAMA 281 1512 9 10227321 10.1001/jama.281.16.1512 1:STN:280:DyaK1M3ktFylsg%3D%3D Gonzales R, Steiner JF, Lum A, Barrett PH. Decreasing antibiotic use in ambulatory practice. JAMA. 1999;281:1512–9.
17. 17. H Seppala T Klaukka I Vuopio-Varkila A Muotiala H Helenius K Lager 1998 The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland N Engl J Med 337 441 6 10.1056/NEJM199708143370701 Seppala H, Klaukka T, Vuopio-Varkila I, Muotiala A, Helenius H, Lager K. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med. 1998;337:441–6.